Pharmafile Logo
Pharmafocus logo
Advanced Search

clinical trial

Showing 15 posts of 189 posts found.

Acorda forced to stop development of drug

November 21, 2016
Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke

Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …

News
c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

Feature
clinical_trial_3

EMA to revise clinical trial guidelines

May 27, 2016
Medical Communications, Research and Development EMA, Guidelines, amend, clinical trial, review, revise

The European Medicines Agency (EMA) has announced that it will conduct a review in an attempt to revise its guidelines …

News
lab

French authorities pins blame on Bial and Biotrial for fatal drug trial

May 24, 2016
Manufacturing and Production, Research and Development Bial, Biotrial, France, blame, clinical trial, death, disaster, minister for health, report

Authorities in France have criticised the pharmaceutical company and the clinical research organisation at the centre of the Rennes clinical …

News

Bayer terminates clinical trial for hypertension due to safety concerns

May 13, 2016
Medical Communications, Research and Development Bayer, clinical trial, deaths, pulmonary hypertension, riociguat, safety concerns

Bayer has terminated a Phase II trial evaluating riociguat in patients with pulmonary hypertension due to fears raised by an …

News
paris

Clinical trial initiated to help Paris attacks victims with PTSD

April 15, 2016
Medical Communications, Research and Development France, clinical trial, mcgill, mcgill university, terror attacks

Victims of the recent Paris terror attacks have been offered the opportunity to take part in a clinical trial, organised …

News
pharma_pill_manufacturing

AstraZeneca and Eli Lilly to enter Phase III on Alzheimer’s clinical trials

April 8, 2016
Medical Communications AZD3293, Alzheimer's, Alzheimers, AstraZeneca, amaranth, clinical trial, lilly, phase III

AstraZeneca and Eli Lilly have announced the continuation of their clinical trial for people with early Alzheimer’s disease into Phase …

News
clinical_trial_4

Clinical trials initiated for novel immunotherapy combo for ovarian cancer

April 7, 2016
Medical Communications, Research and Development MedImmune, cancer research institute, clinical trial, ludwig, ovarian cancer, ventirx

A cross collaboration between industry and not-for-profit organisations will see Ludwig Cancer Research and the Cancer Research Institute partner with …

News
novartis_window

Research shows Novartis’s Entresto reduces cardiovascular death and heart failure

April 4, 2016
Research and Development, Sales and Marketing Entresto, Novartis, Regeneron, Sanofi, cardiovascular, clinical trial, patent

Novartis has announced results from the PARADIGM-HF clinical trial that show that Entresto (sacubitril/valsartan) consistently demonstrated benefit among heart failure …

News
keryx_biopharma

Keryx Biopharmaceuticals announces positive Phase III study results for anaemia treatment

March 30, 2016
Research and Development CKD, anaemia, chronic kidney disease, clinical trial, dialysis, keryx, keryx biopharmaceuticals, kidney, phase 3, phase III

Keryx Biopharmaceuticals (NASDAQ: KERX) has announced positive top-line results for its Phase III study of ferric citrate for the treatment …

News
logo

Phase III trial initiated for enzalutamide in treatment of prostate cancer

March 24, 2016
Research and Development Astellas, Medivation, arches, clinical trial, enzalutamide, phase 3, phase III, prostate cancer

Astellas Pharma (TSE: 4503) and Medivation (NASDAQ:MDVN) have announced the initiation of the ARCHES Phase III clinical trial to evaluate …

News
tablet_production_2

Further positive trial results boost Amgen and UCB’s romosozumab

March 21, 2016
Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, clinical trial, osteoporosis, phase 3, phase III, regulatory approval

Amgen (NASDAQ:AMGN) and UCB (EBR:UCB) have announced positive top line results for romosozumab in men with osteoporosis in the Phase …

News
clinical_trial-web

OncoMed initiates Phase Ib immuno-oncology combination clinical trial

March 18, 2016
Medical Communications, Research and Development Merck, OncoMed, clinical trial, demcizumab, immuno-oncology, immuno-oncology combination, pembrolizumab, phase ib

OncoMed (NASDAQ: OMED) has announced the beginning of its Phase Ib clinical trial to investigate if the combination of demcizumab …

News
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016
Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …

News
sanofi_logo_vertical_2011_4colors

Sanofi Genzyme present positive Phase 2 results for fatal neuromuscular disease treatment

March 4, 2016
Medical Communications, Research and Development Pompe disease, Sanofi, clinical trial, neuromuscular, phase 2

Sanofi Genzyme, the branch of the French-based pharma company that focuses on diseases difficult to diagnose and treat, have published …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026